Although the overall pathological role and molecular mechanisms of YKL-40 in tumorigenesis remains to be established, its angiogenic signature has been reported to regulate tumor development in breast cancer, colon cancer and glioblastoma [54,55]. This evidence concerns the gene CHI3L1 and malignant colon neoplasm.